Report this service

CROACCESS SERVICE PROFILE

Target and Hit Assessment — Quotient Sciences

0.0 (0 Reviews)
32 Views
Scope with confidence. Review the published service details, then contact the CRO directly to confirm methods, timing, availability, and pricing.
  • Response Time
    Contact CRO
  • Delivery Time
    Project dependent
  • Location

About this service

Target and Hit Assessment — Quotient Sciences

At Quotient Sciences, we build each target and hit assessment engagement around context. The right plan depends on what has already been learned, what remains uncertain, which inputs are ready, and how the results will influence the next decision. Our team brings those factors together early so the work has a clear purpose, an agreed path, and deliverables matched to your program.

Our target and hit assessment capabilities

The goal is to find and validate tractable starting points with evidence strong enough to guide investment. Our project plan explains how the work will produce evidence for which hits or candidates should advance, be redesigned, or stop, including what will happen if results fall outside expectations. A clear project brief gives our scientific team room to propose the right approach while keeping scope, schedule, and acceptance criteria visible. Give our team enough non-confidential context to challenge assumptions, identify dependencies, and recommend a realistic path. We are a UK-based drug development and manufacturing accelerator that combines drug substance, drug product, and clinical testing capabilities in a single integrated organization. Their Translational Pharmaceutics platform supports clients across the entire development pathway from candidate selection through commercial launch, significantly compressing timelines and reducing development risk. For sponsors, the practical question is how that broader experience translates into the named team, methods, facilities, quality controls, and availability proposed for this project. Share the program context, available evidence, constraints, and the decision deadline. Resolve material gaps before the scope and quotation are finalized. Agree the methods, responsibilities, dependencies, controls, acceptance criteria, review points, and change process in one executable plan. Run the work against named milestones. Review emerging data and issues at planned gates so our team can adapt without losing traceability. Complete scientific and quality review, explain exceptions and limitations, and connect the final package to an explicit recommendation or next action. This work sits within our Pre-Clinical Research capabilities and is coordinated with the wider program context when the scope requires it.

  • Assay format, controls, library or modality, and throughput.

How we shape the scope

We use the kickoff process to turn a broad request into an executable project. Together, we confirm what is in scope, what is not, which inputs are critical, who owns each decision, and what completion looks like. We surface dependencies early and set a practical review cadence. If the evidence suggests that the original plan should change, we discuss the impact before expanding the work or committing additional resources.

Working with Quotient Sciences

Collaboration is structured around useful decisions rather than routine status reporting. We share what has been completed, what the evidence currently indicates, which questions remain open, and where sponsor input is needed. Reviews can be adjusted to the pace and complexity of the project. This approach keeps the right people involved at the right time and reduces avoidable rework caused by late assumptions or unclear handoffs.

Deliverables built for the next decision

We build reporting requirements into the project plan instead of treating documentation as an afterthought. The team agrees on what must be captured, who will review it, and how revisions will be resolved. At completion, we organize the outputs around the project objective and provide enough context for qualified stakeholders to understand the work performed and the basis for the conclusions. Any proposed follow-on work is discussed separately, with a clear reason for why it may be useful.

Planning your target and hit assessment project with Quotient Sciences

To plan a target and hit assessment project, share the program stage, primary objective, available inputs, known constraints, desired timing, and the decision the work needs to support. We will use that information to frame a focused technical discussion and return a scope that identifies the proposed approach, responsibilities, assumptions, review points, deliverables, and major cost or schedule drivers.

Common questions

What can be included in target and hit assessment?

The proposed scope centers on early discovery work focused on target assessment and identification of promising hits. Exact activities, methods, inputs, outputs, and responsibilities are confirmed with Quotient Sciences for the specific program.

Timing and pricing depend on project stage, complexity, required methods, available inputs, locations, quality requirements, and deliverables. Request a quote from the CRO after sharing a non-confidential project outline.

ONE PLATFORM. THREE WAYS TO MOVE FORWARD.

The right CRO is only part of the decision.

CROaccess helps life science teams move from an open-ended search to a confident partner decision. Choose the level of support that fits your program and your team.

1

Explore

Search CRO profiles and published service listings independently.

2

Match

Describe your program and receive recommendations aligned with services, stage, and location.

3

Partner

Get hands-on support through outreach, comparison, proposal review, and CRO selection.

Official-source researchClear service comparisonsDirect CRO contact